The Massachusetts General Hospital Handbook of Neurology

Authors: Flaherty, Alice W.; Rost, Natalia S.

Title: Massachusetts General Hospital Handbook of Neurology, The, 2nd Edition

Copyright 2007 Lippincott Williams & Wilkins

> Table of Contents > Child Neurology > Neurocutaneous Syndromes

Neurocutaneous Syndromes

Table 41. Distinguishing NF1 and NF2.

  Neurofibromatosis Type I Neurofibromatosis Type II
Incidence 1/3000 1/30,000
Onset of sx Early childhood Adolescence or adulthood
First sx Caf -au-lait spots, freckling 8th nerve problems
Acoustic tumors Almost never bilateral Hallmark of NF2
Typical tumors Neurofibromas, astrocytomas Schwannomas, meningiomas
Nontumor sx Macrocephaly, low IQ, bone dz Retinal dz, juvenile cataracts
Typical spine sx Scoliosis, syringomyelia Intradural tumors, syringomyelia
Screening MRIs? Less useful To catch schwannomas early
Malignancy risk NFS, leukemia, pheo No
Inheritance Chromosome 17, dominant Chromosome 22, dominant
Severity Wide variation within a family Consistent within a family

A. Neurofibromatosis Type I

(von Recklinghausen's dz):

B. Neurofibromatosis Type II

C. Tuberous sclerosis

Autosomal dominant gene on either chromosome 9 or 11, very variable expression. Many spontaneous mutations.

D. Sturge-Weber syndrome (encephalotrigeminal angiomatosis)

Chromosome 3 defect, causes vascular port-wine nevus on face (usually in V1 distribution), contralateral hemiparesis and field cut, ipsilateral glaucoma, seizures, retardation.

E. Incontinentia pigmenti (Bloch-Sulzberger syndrome) and hypomelanosis of Ito

Erythema/bolus lesions only in girl (X-linked dominant) and hypopigmented lesions, respectively. Both in dermatome distribution and associated with seizures, microcephaly, and mental retardation.

F. Von Hippel-Lindau dz

Dominant gene defect on chromosome 3. Not really a neurocutaneous disorder, but we had to stick it somewhere.

Категории